Robert Coury, chief executive of Mylan pharmacutical company. Photograph: Alan Betson / THE IRISH TIMES

Generic drugmaker Mylan says it will take its $31 billion offer for Perrigo directly to shareholders, in what is set to be one of the most high-profil(...)

Joe Papa CEO and president of Perrigo, which has rejected a $29 billion bid from rival Mylan. Photograph: Brenda Fitzsimons / THE IRISH TIMES

Dublin-based Perrigo has rejected a $29 billion bid from generics group Mylan. The company said its board unanimously rejected the $205 per share offe(...)

Joe Papa, CEO and president of Perrigo

The ripple effect of the wave of corporate inversion in the pharma/medtech sector continues to drive the ongoing wave of consolidation.Less than two y(...)

A generic form of the drug Plavix sits on crates at a Mylan Pharmaceuticals distribution centre in North Carolina.  Mylan has offered to acquire Perrigo for about $29 billion in what would be the latest mega-merger among drug makers if it is completed. Photograph: Travis Dove/The New York Times

Drugmaker Mylan offered to buy rival Perrigo for $28.9 billion in a deal that would create a powerhouse for generic medicine. Mylan, which makes abo(...)

Joe Papa CEO and president of Perrigo, which has announced it will acquire Belgium’s Omega Pharma in a €3.6 billion deal.  Photograph: Brenda Fitzsimons / THE IRISH TIMES

Perrigo, the Irish-domiciled consumer pharma group that bought Elan last year, has announced plans to acquire Belgium’s Omega Pharma for €3.6 billi(...)

Steven Cohen: a judge ruled yesterday that the entire case against him and SAC can go forward. Photograph: Scott Eells/Bloomberg

A US federal judge has rejected billionaire investor Steven A Cohen’s bid to dismiss lawsuits by shareholders of pharma firms Elan and Wyeth who clai(...)

Global healthcare firm Perrigo, which has experienced somewhat volatile earnings recently, is due to report fourth quarter results on Thursday.Analyst(...)

President Barack Obama and owner Mark Cuban participating in an event  at the White House. Photograph: Mark Wilson/Getty Images

A billionaire media tycoon with close links to US president Barack Obama has urged investors to sell the shares of companies that shift their headqua(...)

Blister packs of over-the-counter allergy medicines, manufactured by Perrigo. Perrigo agreed to buy Irish drug company Elan for $8.6 billion in 2013, thereby gaining a low-tax base for international expansion. Now it is being cited as a potential acquisition target for larger companies looking to pursue a similar strategy. Photograph: Andrew Harrer/Bloomberg

Dublin based drugmaker Perrigo may join Swiss based Actelion and UK-based medical device company Smith and Nephew as acquisition targets for US healt(...)

Pharmaceuticals made by Actavis, one of the defendants in the lawsuits brought by the US Federal Trade Commission. Photograph: Justin Sullivan/Getty Images

The US Federal Trade Commission is seeking a settlement of $1 billion or more from pharmaceutical companies it has sued for delaying the sale o(...)